Cargando…

p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers

BACKGROUND: p63 is a member of the p53 family that has been implicated in maintenance of epithelial stem cell compartments. Previous studies demonstrated that p63 is downregulated in muscle-invasive bladder cancers, but the relationship between p63 expression and survival is not clear. METHODOLOGY/P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Woonyoung, Shah, Jay B., Tran, Mai, Svatek, Robert, Marquis, Lauren, Lee, I-Ling, Yu, Dasom, Adam, Liana, Wen, Sijin, Shen, Yu, Dinney, Colin, McConkey, David J., Siefker-Radtke, Arlene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254658/ https://www.ncbi.nlm.nih.gov/pubmed/22253920 http://dx.doi.org/10.1371/journal.pone.0030206

Ejemplares similares

Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer
por: Ochoa, Andrea E., et al.
Publicado: (2016)

Inhibition of Inducible Heat Shock Protein-70 (Hsp72) Enhances Bortezomib-Induced Cell Death in Human Bladder Cancer Cells
por: Qi, Wei, et al.
Publicado: (2013)

Intrinsic subtypes and bladder cancer metastasis
por: McConkey, David J., et al.
Publicado: (2016)

Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting
por: Cheng, Tiewei, et al.
Publicado: (2013)

Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer
por: Yang, Guoliang, et al.
Publicado: (2020)

Update on bladder cancer molecular subtypes
por: Fong, Megan Hoi Yan, et al.
Publicado: (2020)

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
por: Dadhania, Vipulkumar, et al.
Publicado: (2016)

Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis
por: Roth, Beat, et al.
Publicado: (2016)

Autophagy is required for crizotinib-induced apoptosis in MET-amplified gastric cancer cells
por: Schroeder, Rebecca D., et al.
Publicado: (2017)

Erdafitinib for locally advanced or metastatic urothelial carcinoma
por: Siefker-Radtke, Arlene O, et al.
Publicado: (2022)

Assessment of Luminal and Basal Phenotypes in Bladder Cancer
por: Guo, Charles C., et al.
Publicado: (2020)

ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma
por: Kim, Michael P., et al.
Publicado: (2011)

Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation
por: Plote, Devin, et al.
Publicado: (2019)

Vero cells gain renal tubule markers in low-calcium and magnesium chemically defined media
por: Logan, Megan, et al.
Publicado: (2022)

Identification of TIAM1 as a Potential Synthetic-Lethal-like Gene in a Defined Subset of Hepatocellular Carcinoma
por: Permtermsin, Chalermsin, et al.
Publicado: (2023)

Organoid culture of bladder cancer cells
por: Yoshida, Takahiro, et al.
Publicado: (2018)

Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study
por: Ji, Niannian, et al.
Publicado: (2021)

Mutational Landscape and Environmental Effects in Bladder Cancer
por: Hayashi, Takuji, et al.
Publicado: (2020)

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
por: Kamoun, Aurélie, et al.
Publicado: (2019)

A Brief Measure of Parental Wellbeing for Use in Evaluations of Family-Centred Interventions for Children with Developmental Disabilities
por: McConkey, Roy
Publicado: (2020)

Responding to Autism in Low and Middle Income Countries (Lmic): What to Do and What Not to Do
por: McConkey, Roy
Publicado: (2022)

TP63‐mutation as a cause of prenatal lethal multicystic dysplastic kidneys
por: Friedmann, Isabel, et al.
Publicado: (2020)

The expression of p63 in bladder cancer vs. chronic bilharzial bladder
por: Mursi, Khaled, et al.
Publicado: (2013)

Administración financiera por objetivos
por: McConkey, Dale D.
Publicado: (1982)

12 guiding premises of pediatric cochlear implant habilitation
por: McConkey Robbins, Amy
Publicado: (2018)

Tumor heterogeneity in muscle-invasive bladder cancer
por: Kang, Ho Won, et al.
Publicado: (2020)

Murine CD4+ T cell subsets defined
Publicado: (1988)

Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer
por: Zhou, Xunian, et al.
Publicado: (2021)

The origin of bladder cancer from mucosal field effects
por: Bondaruk, Jolanta, et al.
Publicado: (2022)

The origin of bladder cancer from mucosal field effects
por: Bondaruk, Jolanta, et al.
Publicado: (2022)

THE RELATION OF VITAMIN C DEFICIENCY TO INTESTINAL TUBERCULOSIS IN THE GUINEA PIG
por: McConkey, Mack, et al.
Publicado: (1933)

Topics in chemical physics
por: Prock, Alfred, et al.
Publicado: (1962)

Insiders’ Insight: Discrimination against Indigenous Peoples through the Eyes of Health Care Professionals
por: Wylie, Lloy, et al.
Publicado: (2018)

Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection
por: Tedford, Ellen, et al.
Publicado: (2017)

Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer
por: Lerner, Seth P., et al.
Publicado: (2016)

Three-dimensional organoid culture reveals involvement of Wnt/β-catenin pathway in proliferation of bladder cancer cells
por: Yoshida, Takahiro, et al.
Publicado: (2018)

Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting
por: Lerner, Seth P., et al.
Publicado: (2016)

Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer
por: Jayaratna, Isuru S., et al.
Publicado: (2015)

Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma
por: Alhalabi, Omar, et al.
Publicado: (2021)

A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent
por: Sharma, Padmanee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6f7vn4ecgliohes3cd7qmgv7vf